RNA, U6 small nuclear 95, pseudogene (RNU6-95P)

RNU6-95P is classified as a pseudogene, meaning it is a nonfunctional remnant of the U6 small nuclear RNA gene that has lost its capacity to encode a functional product[4]. The parental U6 snRNA is involved in the splicing of precursor messenger RNAs in the nucleus, functioning centrally within the spliceosome complex[1][3][5]. Pseudogenes such as RNU6-95P are widely distributed in the genome and do not code for proteins; though, some pseudogenes have been implicated in RNA-level regulatory roles, such as miRNA decoy, lncRNA formation, or competing for RNA-binding proteins[2]. No evidence indicates RNU6-95P itself participates in such activities, nor does it serve as a therapeutic target, biomarker, or have pharmacological relevance. There are no known drugs interacting with this pseudogene, and it is not classified within traditional molecular families like receptor, enzyme, or transporter. RNU6-95P is not a functional molecule or therapeutic target; it is a noncoding pseudogene. Its mention as a receptor or drug target would be incorrect. There is no evidence for direct biological activity, disease association, or pharmacological exploitation of RNU6-95P — its scientific relevance is limited to its annotation in genome databases and possible theoretical long-range genome effects, which have not been documented for this specific pseudogene[4][2].

Other names

RNU6-95PRNA, U6 small nuclear 95 pseudogeneU6-95P

None identified; not a druggable or functional therapeutic target